Home » Topics » BioWorld Science, Hematologic

BioWorld Science, Hematologic
RSS

MR-33 as a potential treatment for DIC with reduced hemorrhagic risk

Dec. 12, 2000

AstraZeneca presents new carboxypeptidase U inhibitors and use thereof

Dec. 11, 2000

Heparin inhibition of complement activation: comparative effects of Neutralase and protamine

Dec. 11, 2000

Belgian group maintains focus on discovering new TxA2 inhibitors related to torasemide

Dec. 7, 2000

International patent issued to Sanofi-Synthelabo for new anticoagulants

Dec. 6, 2000

Progress on Coagulin-B hemophilia B gene therapy reported at Hematology meeting

Dec. 5, 2000

R-102444, a prodrug-type 5-HT2 antagonist, as a promising candidate for thrombosis

Nov. 30, 2000

Anticoagulants targeting thrombin developed at ADIR

Nov. 29, 2000

Potent new antiplatelet agent synthesized at Welfide acts as 5-HT2 receptor antagonist

Nov. 28, 2000

Merck's new integrin receptor antagonists for thrombosis, osteoporosis, atherosclerosis

Nov. 24, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 21, 2026.
ALN-5288 lowers tau levels in preclinical models
BioWorld Science
Pathological tau accumulation is a key driver of neurodegeneration in Alzheimer’s disease (AD) and other tauopathies such as progressive supranuclear palsy....
LIT-002 is strong candidate for autism and neuropathic pain
BioWorld Science
Researchers from the University of Strasbourg and the Centre National de la Recherche Scientifique (CNRS) have presented data on LIT-002, a nonpeptide oxytocin...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 21, 2026
New biomarker may improve RSV drug screening
BioWorld
Respiratory syncytial virus (RSV) infection is responsible for 3.2 million hospital admissions and about 118,000 deaths in children under 5 years of age. The...